---
title: Isomerase vs Richter BioLogics
slug_a: isomerase
slug_b: richterbiologics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/isomerase/richterbiologics
---

# Isomerase vs Richter BioLogics

Side-by-side profile data from each company listing on this directory.

## Isomerase

- Profile: [/companies/isomerase](/companies/isomerase)

Isomerase — Isomerase is a synthetic biology company offering fee-for-service lab work, consultancy, and bioproduction, process development and scale-up for pharma, agritech and chemical clients. Its platform covers enzyme engineering, microbial hosts and cell-free protein synthesis.

Services: 9. Modalities: 4. Indications: 0. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (9).

### Services

- Discovery Research
- Protein Engineering
- Analytical Method Development & Validation
- Bioinformatics & Data Science
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Process Development
- Technology Transfer

### Modalities

- Small Molecule
- Biologics (Other)
- Peptide
- Synthetic Biology

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Expression: Microbial
- Expression: Cell-Free

## Richter BioLogics

- Profile: [/companies/richterbiologics](/companies/richterbiologics)

Richter BioLogics — Germany-based CDMO specializing in GMP-compliant microbial production of recombinant proteins, peptides, plasmid DNA, and bacterial vaccines with bioreactor capacity up to 1,500 litres and regulatory clearance from FDA, EMA, ANVISA, PMDA, and MFDS.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 4. The strongest documented coverage currently appears in services (9).

### Services

- Recombinant Protein Manufacturing
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Peptide Manufacturing
- Vaccine Manufacturing
- Process Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Biologics (Other)
- Peptide
- Vaccine

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Microbial